Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

The prevalence of fibromyalgia among patients with hepatitis B virus infection.

Ozsahin M, Gonen I, Ermis F, Oktay M, Besir FH, Kutlucan A, Sahin A, Ataoglu S.

Int J Clin Exp Med. 2013 Sep 25;6(9):804-8. eCollection 2013.

2.

Fibromyalgia frequency in hepatitis B carriers.

Adak B, Tekeoğlu I, Ediz L, Budancamanak M, Yazgan T, Karahocagil K, Demirel A.

J Clin Rheumatol. 2005 Jun;11(3):157-9.

PMID:
16357736
3.

Fibromyalgia incidence among patients with hepatitis B infection.

Yazmalar L, Deveci Ö, Batmaz İ, İpek D, Çelepkolu T, Alpaycı M, Hattapoğlu E, Akdeniz D, Sarıyıldız MA.

Int J Rheum Dis. 2016 Jul;19(7):637-43. doi: 10.1111/1756-185X.12593. Epub 2015 Jul 1.

PMID:
26133007
4.

Hepatitis B virus genotype D prevails in patients with persistently elevated or normal ALT levels in Turkey.

Yalcin K, Degertekin H, Bahcecioglu IH, Demir A, Aladag M, Yildirim B, Horasanli S, Ciftci S, Badur S.

Infection. 2004 Feb;32(1):24-9.

PMID:
15007739
5.

[Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].

Sayan M, Mutlu B, Erdoğan S, Meriç M, Willke A.

Mikrobiyol Bul. 2007 Jan;41(1):87-93. Turkish.

PMID:
17427556
6.

Fibromyalgia-associated hepatitis C virus infection.

Rivera J, de Diego A, Trinchet M, García Monforte A.

Br J Rheumatol. 1997 Sep;36(9):981-5.

PMID:
9376995
7.

Chronic hepatitis B virus infection in Asian countries.

Merican I, Guan R, Amarapuka D, Alexander MJ, Chutaputti A, Chien RN, Hasnian SS, Leung N, Lesmana L, Phiet PH, Sjalfoellah Noer HM, Sollano J, Sun HS, Xu DZ.

J Gastroenterol Hepatol. 2000 Dec;15(12):1356-61. Review.

PMID:
11197043
8.

Hepatitis B infection and changes in interferon-alpha and -gamma production in patients with systemic lupus erythematosus in Taiwan.

Lu CL, Tsai ST, Chan CY, Hwang SJ, Tsai CY, Wu JC, Lu RH, Lin BC, Lee SD.

J Gastroenterol Hepatol. 1997 Apr;12(4):272-6.

PMID:
9195365
9.
10.

Prevalence and virological profiles of hepatitis B infection in human immunodeficiency virus patients.

Attia KA, Eholié S, Messou E, Danel C, Polneau S, Chenal H, Toni T, Mbamy M, Seyler C, Wakasugi N, N'dri-Yoman T, Anglaret X.

World J Hepatol. 2012 Jul 27;4(7):218-23. doi: 10.4254/wjh.v4.i7.218.

11.

Evaluation of hepatitis B viraemia levels in patients with HBeAg-negative chronic hepatitis B virus infection.

Atay AE, Seven G, Yalcin K, Pasa S, Degertekin H.

J Int Med Res. 2012;40(5):1891-6.

PMID:
23206472
12.

Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages.

Whittle HC, Maine N, Pilkington J, Mendy M, Fortuin M, Bunn J, Allison L, Howard C, Hall A.

Lancet. 1995 Apr 29;345(8957):1089-92.

PMID:
7715343
13.

Level of hepatitis B virus DNA in inactive carriers with persistently normal levels of alanine aminotransferase.

Chu CM, Chen YC, Tai DI, Liaw YF.

Clin Gastroenterol Hepatol. 2010 Jun;8(6):535-40. doi: 10.1016/j.cgh.2010.03.006. Epub 2010 Mar 19.

PMID:
20304099
14.

Role of hepatitis B surface antigen (HBsAg) in identifying true inactive HBsAg carriers infected with genotype C hepatitis B virus.

Yim SY, Um SH, Jung JY, Seo YS, Yim HJ, Ryu HS, Chun HJ, Jeen YT, Kim CD, Keum B, Lee HS.

J Clin Gastroenterol. 2014 Feb;48(2):166-71. doi: 10.1097/MCG.0b013e3182a4711d.

PMID:
24045280
15.

Predictive value of HBsAg quantification for determining the clinical course of genotype C HBeAg-negative carriers.

Park H, Lee JM, Seo JH, Kim HS, Ahn SH, Kim DY, Han KH, Chon CY, Park JY.

Liver Int. 2012 May;32(5):796-802. doi: 10.1111/j.1478-3231.2011.02693.x. Epub 2011 Nov 30.

PMID:
22128792
16.
17.

A paucity of liver disease in Canadian Inuit with chronic hepatitis B virus, subgenotype B6 infection.

Minuk GY, Macrury S, Uhanova J, Caouette S, Coleman N, Cummings K, Larke B, Vardy L, Triet Huyn C, Osiowy C.

J Viral Hepat. 2013 Dec;20(12):890-6. doi: 10.1111/jvh.12121. Epub 2013 May 29.

PMID:
24304459
18.

Factors associated with spontaneous HBsAg clearance in chronic hepatitis B patients followed at a university hospital.

Ferreira SC, Chachá SG, Souza FF, Teixeira AC, Santana RC, Villanova MG, Zucoloto S, Ramalho LN, Perdoná GS, Passos AD, Martinelli AL.

Ann Hepatol. 2014 Nov-Dec;13(6):762-70.

19.

[The follow-up of serum aminotransferase levels and investigation of hepatitis B virus load in inactive HBsAg carriers].

Olut AI, Ozünlü H, Bozdağ H, Ozkalay N.

Mikrobiyol Bul. 2007 Jul;41(3):429-33. Turkish.

PMID:
17933254
20.

Significance of hepatitis B viremia levels determined by a quantitative polymerase chain reaction assay in patients with hepatitis B e antigen-negative chronic hepatitis B virus infection.

Manesis EK, Papatheodoridis GV, Sevastianos V, Cholongitas E, Papaioannou C, Hadziyannis SJ.

Am J Gastroenterol. 2003 Oct;98(10):2261-7.

PMID:
14572577

Supplemental Content

Support Center